NDA
Clearside Biomedical Provides New Drug Application Update for XIPEREᵀᴹ (triamcinolone acetonide suprachoroidal injectable suspension)
Clearside Biomedical
PR-M08-19-NI-077Aug 27, 2019
New Drug Application
Janssen Submits Supplemental New Drug Application to U.S. FDA for INVOKANA® (canagliflozin) for the Treatment of Chronic Kidney Disease in Patients with Type 2 Diabetes
Janssen Pharmaceutical Companies
PR-M04-19-NI-008Apr 02, 2019
Macular Degeneration
More Positive Results for Novartis Eye Drug Brolucizumab
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-002Nov 05, 2018
New Drug Application
Janssen Submits New Drug Application to U.S. FDA Seeking Approval of Erdafitinib for the Treatment of Metastatic Urothelial Cancer
Janssen Pharmaceutical Companies
PR-M09-18-NI-083Sep 26, 2018
NDA
Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion
Ortho Dermatologics
PR-M09-18-NI-057Sep 19, 2018
Drug Application
Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA
Nektar Therapeutics
PR-M08-18-NI-011Aug 03, 2018
Drug Application
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
Bayer
PR-M05-18-NI-115May 31, 2018